Invention Application
- Patent Title: S1P MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
-
Application No.: US18924230Application Date: 2024-10-23
-
Publication No.: US20250041266A1Publication Date: 2025-02-06
- Inventor: Philippe Michel Rene BOUILLOT , Frank DAHLKE , Eric LEGANGNEUX , Emeric REYNAUD , Erik WALLSTROM
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61K9/20
Abstract:
The present invention relates to siponimod (BAB312) for use in the treatment of an autoimmune disease, wherein an immediate release dosage form is administered once daily to a patient as maintenance regimen and wherein the patient has experienced a specific titration regimen with siponimod beforehand.
Information query
